N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine

C174H379N33O11 — CID 161102626

IUPACN,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine
SMILESCC(=O)N1CCN(C(C)C)CC1.CC(C)CN1CCN(C(C)C)CC1.CC(C)N(C)CCN(C)C.CC(C)N(C)CCN1CCCC1.CC(C)N(C)CCN1CCN(C)CC1.CC(C)N(C)CCN1CCOCC1.CC(C)N1CCC(N2CCN(C)CC2)CC1.CC(C)N1CCC(N2CCN(C)CC2)CC1.CC(C)N1CCC(N2CCOCC2)CC1.CC(C)N1CCCN(C)CC1.CC(C)N1CCN(C)CC1.CC(C)OCCN(C)C.CC(C)OCCN1CCCC1.CC(C)OCCN1CCCCC1.CC(C)OCCN1CCN(C)CC1.CC(C)OCCN1CCOCC1.CCN1CCN(C(C)C)CC1.COCCOC(C)C
InChIInChI=1S/2C13H27N3.C12H24N2O.C11H25N3.C11H24N2.2C10H22N2O.C10H22N2.C10H21NO.C9H18N2O.2C9H20N2.C9H19NO2.C9H19NO.C8H18N2.C8H20N2.C7H17NO.C6H14O2/c2*1-12(2)15-6-4-13(5-7-15)16-10-8-14(3)9-11-16;1-11(2)13-5-3-12(4-6-13)14-7-9-15-10-8-14;1-11(2)13(4)7-10-14-8-5-12(3)6-9-14;1-10(2)9-12-5-7-13(8-6-12)11(3)4;1-10(2)13-9-8-12-6-4-11(3)5-7-12;1-10(2)11(3)4-5-12-6-8-13-9-7-12;1-10(2)11(3)8-9-12-6-4-5-7-12;1-10(2)12-9-8-11-6-4-3-5-7-11;1-8(2)10-4-6-11(7-5-10)9(3)12;1-9(2)11-6-4-5-10(3)7-8-11;1-4-10-5-7-11(8-6-10)9(2)3;1-9(2)12-8-5-10-3-6-11-7-4-10;1-9(2)11-8-7-10-5-3-4-6-10;1-8(2)10-6-4-9(3)5-7-10;1-8(2)10(5)7-6-9(3)4;1-7(2)9-6-5-8(3)4;1-6(2)8-5-4-7-3/h2*12-13H,4-11H2,1-3H3;11-12H,3-10H2,1-2H3;11H,5-10H2,1-4H3;10-11H,5-9H2,1-4H3;2*10H,4-9H2,1-3H3;10H,4-9H2,1-3H3;10H,3-9H2,1-2H3;8H,4-7H2,1-3H3;2*9H,4-8H2,1-3H3;9H,3-8H2,1-2H3;9H,3-8H2,1-2H3;8H,4-7H2,1-3H3;8H,6-7H2,1-5H3;7H,5-6H2,1-4H3;6H,4-5H2,1-3H3
InChIKeyUIQBRSALGCPMLC-UHFFFAOYSA-N
MW3110.17 g/mol
LogP18.72
Rot. Bonds54

About N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine

N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine (PubChem CID 161102626) has the molecular formula C174H379N33O11 and a molecular weight of 3110.17 g/mol. Its IUPAC name is N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine.

Molecular Properties

Compound NameN,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine
PubChem CID161102626
Molecular FormulaC174H379N33O11
Molecular Weight3110.17 g/mol
Exact Mass3108.01
IUPAC NameN,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine
SMILESCC(=O)N1CCN(C(C)C)CC1.CC(C)CN1CCN(C(C)C)CC1.CC(C)N(C)CCN(C)C.CC(C)N(C)CCN1CCCC1.CC(C)N(C)CCN1CCN(C)CC1.CC(C)N(C)CCN1CCOCC1.CC(C)N1CCC(N2CCN(C)CC2)CC1.CC(C)N1CCC(N2CCN(C)CC2)CC1.CC(C)N1CCC(N2CCOCC2)CC1.CC(C)N1CCCN(C)CC1.CC(C)N1CCN(C)CC1.CC(C)OCCN(C)C.CC(C)OCCN1CCCC1.CC(C)OCCN1CCCCC1.CC(C)OCCN1CCN(C)CC1.CC(C)OCCN1CCOCC1.CCN1CCN(C(C)C)CC1.COCCOC(C)C
InChIInChI=1S/2C13H27N3.C12H24N2O.C11H25N3.C11H24N2.2C10H22N2O.C10H22N2.C10H21NO.C9H18N2O.2C9H20N2.C9H19NO2.C9H19NO.C8H18N2.C8H20N2.C7H17NO.C6H14O2/c2*1-12(2)15-6-4-13(5-7-15)16-10-8-14(3)9-11-16;1-11(2)13-5-3-12(4-6-13)14-7-9-15-10-8-14;1-11(2)13(4)7-10-14-8-5-12(3)6-9-14;1-10(2)9-12-5-7-13(8-6-12)11(3)4;1-10(2)13-9-8-12-6-4-11(3)5-7-12;1-10(2)11(3)4-5-12-6-8-13-9-7-12;1-10(2)11(3)8-9-12-6-4-5-7-12;1-10(2)12-9-8-11-6-4-3-5-7-11;1-8(2)10-4-6-11(7-5-10)9(3)12;1-9(2)11-6-4-5-10(3)7-8-11;1-4-10-5-7-11(8-6-10)9(2)3;1-9(2)12-8-5-10-3-6-11-7-4-10;1-9(2)11-8-7-10-5-3-4-6-10;1-8(2)10-6-4-9(3)5-7-10;1-8(2)10(5)7-6-9(3)4;1-7(2)9-6-5-8(3)4;1-6(2)8-5-4-7-3/h2*12-13H,4-11H2,1-3H3;11-12H,3-10H2,1-2H3;11H,5-10H2,1-4H3;10-11H,5-9H2,1-4H3;2*10H,4-9H2,1-3H3;10H,4-9H2,1-3H3;10H,3-9H2,1-2H3;8H,4-7H2,1-3H3;2*9H,4-8H2,1-3H3;9H,3-8H2,1-2H3;9H,3-8H2,1-2H3;8H,4-7H2,1-3H3;8H,6-7H2,1-5H3;7H,5-6H2,1-4H3;6H,4-5H2,1-3H3
InChIKeyUIQBRSALGCPMLC-UHFFFAOYSA-N
XLogP18.72
TPSA216.29 Ų
H-Bond Donors
H-Bond Acceptors43
Rotatable Bonds54
Heavy Atoms218
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003110.17
LogP ≤ 518.72
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine?
The IUPAC name of N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine (CID 161102626) is N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine.
What is the SMILES notation for N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine?
The canonical SMILES for N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine is CC(=O)N1CCN(C(C)C)CC1.CC(C)CN1CCN(C(C)C)CC1.CC(C)N(C)CCN(C)C.CC(C)N(C)CCN1CCCC1.CC(C)N(C)CCN1CCN(C)CC1.CC(C)N(C)CCN1CCOCC1.CC(C)N1CCC(N2CCN(C)CC2)CC1.CC(C)N1CCC(N2CCN(C)CC2)CC1.CC(C)N1CCC(N2CCOCC2)CC1.CC(C)N1CCCN(C)CC1.CC(C)N1CCN(C)CC1.CC(C)OCCN(C)C.CC(C)OCCN1CCCC1.CC(C)OCCN1CCCCC1.CC(C)OCCN1CCN(C)CC1.CC(C)OCCN1CCOCC1.CCN1CCN(C(C)C)CC1.COCCOC(C)C.
What is the InChIKey of N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine?
The InChIKey is UIQBRSALGCPMLC-UHFFFAOYSA-N. The full InChI is InChI=1S/2C13H27N3.C12H24N2O.C11H25N3.C11H24N2.2C10H22N2O.C10H22N2.C10H21NO.C9H18N2O.2C9H20N2.C9H19NO2.C9H19NO.C8H18N2.C8H20N2.C7H17NO.C6H14O2/c2*1-12(2)15-6-4-13(5-7-15)16-10-8-14(3)9-11-16;1-11(2)13-5-3-12(4-6-13)14-7-9-15-10-8-14;1-11(2)13(4)7-10-14-8-5-12(3)6-9-14;1-10(2)9-12-5-7-13(8-6-12)11(3)4;1-10(2)13-9-8-12-6-4-11(3)5-7-12;1-10(2)11(3)4-5-12-6-8-13-9-7-12;1-10(2)11(3)8-9-12-6-4-5-7-12;1-10(2)12-9-8-11-6-4-3-5-7-11;1-8(2)10-4-6-11(7-5-10)9(3)12;1-9(2)11-6-4-5-10(3)7-8-11;1-4-10-5-7-11(8-6-10)9(2)3;1-9(2)12-8-5-10-3-6-11-7-4-10;1-9(2)11-8-7-10-5-3-4-6-10;1-8(2)10-6-4-9(3)5-7-10;1-8(2)10(5)7-6-9(3)4;1-7(2)9-6-5-8(3)4;1-6(2)8-5-4-7-3/h2*12-13H,4-11H2,1-3H3;11-12H,3-10H2,1-2H3;11H,5-10H2,1-4H3;10-11H,5-9H2,1-4H3;2*10H,4-9H2,1-3H3;10H,4-9H2,1-3H3;10H,3-9H2,1-2H3;8H,4-7H2,1-3H3;2*9H,4-8H2,1-3H3;9H,3-8H2,1-2H3;9H,3-8H2,1-2H3;8H,4-7H2,1-3H3;8H,6-7H2,1-5H3;7H,5-6H2,1-4H3;6H,4-5H2,1-3H3.
What are the key properties of N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine?
N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine has a molecular weight of 3110.17 g/mol, XLogP of 18.72, 54 rotatable bonds, 0 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-dimethyl-2-propan-2-yloxyethanamine;1-ethyl-4-propan-2-ylpiperazine;2-(2-methoxyethoxy)propane;N-methyl-N-[2-(4-methylpiperazin-1-yl)ethyl]propan-2-amine;N-methyl-N-(2-morpholin-4-ylethyl)propan-2-amine;1-methyl-4-propan-2-yl-1,4-diazepane;1-methyl-4-(2-propan-2-yloxyethyl)piperazine;1-methyl-4-propan-2-ylpiperazine;bis(1-methyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine);1-(2-methylpropyl)-4-propan-2-ylpiperazine;N-methyl-N-(2-pyrrolidin-1-ylethyl)propan-2-amine;4-(2-propan-2-yloxyethyl)morpholine;1-(2-propan-2-yloxyethyl)piperidine;1-(2-propan-2-yloxyethyl)pyrrolidine;1-(4-propan-2-ylpiperazin-1-yl)ethanone;4-(1-propan-2-ylpiperidin-4-yl)morpholine;N,N,N'-trimethyl-N'-propan-2-ylethane-1,2-diamine is sourced from PubChem (CID 161102626), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).